Tactile Medical to Present at the Piper Sandler 37th Annual Healthcare Conference
Tactile Medical (Nasdaq: TCMD) said management will participate in the Piper Sandler 37th Annual Healthcare Conference at the Lotte New York Palace in New York, NY from December 2–4, 2025.
Rhea-AI Summary
Tactile Medical (Nasdaq: TCMD) said management will participate in the Piper Sandler 37th Annual Healthcare Conference at the Lotte New York Palace in New York, NY from December 2–4, 2025.
The company will take part in a fireside chat on December 2, 2025 at 8:00 a.m. Central Time. A live audio webcast will be available in the Events & Webcasts section of the company investor relations site (http://investors.tactilemedical.com), and an archive will be posted for replay after the conference.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TCMD
On Nov 19, the first trading day after this news, TCMD closed 4.48% above the previous close.
Data tracked by StockTitan Argus for the Nov 19 session.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MINNEAPOLIS, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with chronic disorders, today announced that management will participate in the Piper Sandler 37th Annual Healthcare Conference, which is being held at the Lotte New York Palace in New York, NY from December 2nd – 4th. Management will participate in a fireside chat on Tuesday, December 2nd at 8:00 a.m. Central Time.
A live audio webcast of the fireside chat will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.
About Tactile Systems Technology, Inc. (DBA Tactile Medical)
Tactile Medical is a leader in developing and marketing at-home therapies for people suffering from underserved, chronic conditions including lymphedema, lipedema, chronic venous insufficiency and chronic pulmonary disease by helping them live better and care for themselves at home. Tactile Medical collaborates with clinicians to expand clinical evidence, raise awareness, increase access to care, reduce overall healthcare costs and improve the quality of life for tens of thousands of patients each year.
Investor Inquiries:
Sam Bentzinger
Gilmartin Group
investorrelations@tactilemedical.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.